Genetic variants of flavin-containing monooxygenase (FMO) 1 and FMO3 in 5887 dogs influenced oxygenations of probe substrates benzydamine, trimethylamine, and methyl p-tolyl sulfide.

Abstract excerpt

NADPH-dependent flavin-containing monooxygenases (FMOs; EC 1.14.13.8) mediate the oxygenation of various N- or S-containing molecules. Human FMO1 and FMO3 metabolize the substrates benzydamine, trimethylamine, and methyl p-tolyl sulfide in the kidney and liver, respectively. FMO genetic variants contribute to variability in metabolic activity among individuals. However, genetic variants in dogs used in drug...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Dogs
• Share to FMO3 gene